Mali vs Mongolia: The number of people with susceptibility test result for rifampicin
Mali
1,234
in 2021
Mongolia
1,106
in 2021
Mali rank
61st
Mongolia rank
64th
The number of people with susceptibility test result for rifampicin over time
- Mali
- Mongolia
How they compare
Mali currently reports 1,234 against 1,106 in Mongolia, a difference of 128.
That makes Mali's figure about 1.1 times Mongolia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Mongolia ahead.
Mali ranks 61st and Mongolia ranks 64th of 155 countries.
Across the 2 decades both report, Mali averaged higher in 1 and Mongolia in 1.
Head to head by decade
| Decade | Mali | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 141 | 1,235 | 1,094 | Mongolia |
| 2020s | 1,823 | 1,359 | 464 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mali or Mongolia?
- Mali, at 1,234 against 1,106 in Mongolia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mali and Mongolia?
- 128, with Mali ahead.
- How many years of comparable data are there for Mali and Mongolia?
- 5 years are reported by both, from 2017 to 2021.
- How do Mali and Mongolia rank globally for the number of people with susceptibility test result for rifampicin?
- Mali ranks 61st and Mongolia ranks 64th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.